|
Philanthropic Program Case Studies: International Program
Pfizer Inc.
Through corporate giving programs and the Pfizer Foundation, Pfizer Inc. focuses its charitable giving (in 2000, $300 million worldwide in cash and products) on three areas:
- Access to quality healthcare and education
- Nurturing innovation
- Supporting community involvement by Pfizer employees
Unlike many pharmaceutical manufacturers with major HIV/AIDS giving programs, Pfizer does not manufacture any of the antiretrovirals used to treat HIV infection—its Diflucan and Zithromax, however, are important treatments for some of the life-threatening opportunistic infections that strike AIDS patients.
- After successfully implementing the South African Diflucan Partnership Program in cooperation with the South African Ministry of Health, Pfizer expanded the program to distribute the antifungal medication to low-income AIDS patients in heavily impacted countries worldwide.
- In countries where Pfizer has established Diflucan Partnerships, the company also makes targeted grants (Pfizer does not accept unsolicited proposals) to local non-governmental organizations to provide health literacy, patient communication, and patient education programs.
- Pfizer is providing construction costs and seed money for the first large-scale HIV/AIDS clinic and training center in Africa. The clinic, in Uganda, will train medical personnel from across the continent on the latest treatment options and will improve the patient standard of care.
- The Pfizer Foundation provided support to the Uganda AIDS Commission to study the efficacy of community-based HIV/AIDS prevention efforts. The study will evaluate best practices in several districts that could be expanded both within and outside of the country.
- In the United States, Pfizer's Patient Assistance Program has donated more than $32 million of Diflucan to indigent patients. Through its employee matching gift program, contributions to HIV/AIDS organizations have totaled $225,000 since 1996, and in 2001, Pfizer employees contributed $32,800 to HIV/AIDS organizations.
|
